azathioprine has been researched along with acetylcysteine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (39.47) | 29.6817 |
2010's | 22 (57.89) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ahmad, M; Al-Shabanah, OA; Gado, A; Raza, M | 1 |
Arriaza, E; Cara, C; Di Paola, M; Escribano, O; Fernández-Moreno, MD; Fueyo, JA; Guijarro, LG; Lorusso, M; Menor, C; Olleros, T; Román, ID | 1 |
Behr, J; Buhl, R; Capron, F; Corvasce, G; Costabel, U; De Vuyst, P; Dekhuijzen, R; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Montanari, M; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B | 1 |
Hunninghake, GW | 1 |
Nathan, SD | 1 |
Wells, AU | 1 |
Eickelberg, O; Günther, A; Markart, P; Seeger, W | 1 |
Meng, Q; Shen, C; Wu, YT; Yin, J; Yu, JP | 1 |
Collard, HR; King, TE; Walter, N | 1 |
Bennett, L; Crouse, R; Feldstein, D | 1 |
Cottin, V | 2 |
Behr, J; Boissard, G; Buhl, R; Costabel, U; De Vuyst, P; Dekhuijzen, RP; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B | 1 |
Eckman, MH; Hagaman, JT; Kinder, BW | 1 |
Demedts, MG; Thomeer, M; Wuyts, WA | 1 |
Behr, J; Costabel, U; Worth, H | 1 |
McGrath, EE; Millar, AB | 1 |
Behr, J; Costabel, U; Cottin, V; Poletti, V; Wells, AU | 1 |
Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ; Raghu, G | 1 |
Behr, J | 1 |
Hanada, S; Kishi, K; Uruga, H | 1 |
Hirano, S; Iikura, M; Izumi, S | 1 |
Hashemi Sadraei, N; Masjedi, MR; Riahi, T | 1 |
Alfaro, TM; Cordeiro, CR; Freitas, S | 1 |
Ancochea, J; Valenzuela, C | 1 |
Anstrom, KJ; de Andrade, JA; King, TE; Martinez, FJ; Raghu, G | 1 |
Covvey, JR; Mancl, EE | 1 |
Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
Álvarez-Sala Walther, R; Gómez Carrera, L | 1 |
Canestaro, WJ; Devine, BE; Forrester, SH; Ho, L; Raghu, G | 1 |
Banfield, L; Coyne, J; Cui, S; Guy, B; Helmeczi, W; Husnudinov, R; Jones, A; Khalid, MF; Kolb, MR; Mah, J; Pitre, T; Scallan, C; Su, J; Zeraatkar, D; Zhang, M | 1 |
9 review(s) available for azathioprine and acetylcysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Pulmonary fibrosis--a therapeutic dilemma?].
Topics: Acetylcysteine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Benzamides; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anticoagulants; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Pyridones; Quality of Life; Recombinant Proteins | 2006 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors | 2006 |
Newer modes of treating interstitial lung disease.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Azathioprine; Humans; Lung Diseases, Interstitial; Lung Transplantation; Palliative Care; Pyridones | 2011 |
Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Azathioprine; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Prednisone; Pyridones; Randomized Controlled Trials as Topic | 2014 |
Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azathioprine; Bayes Theorem; Bosentan; Endothelin Receptor Antagonists; Enzyme Inhibitors; Etanercept; Free Radical Scavengers; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Immunosuppressive Agents; Indoles; Interferon-gamma; Phenylpropionates; Pyridazines; Pyridones; Pyrimidines; Recombinant Proteins; Sulfonamides; Vital Capacity; Warfarin | 2016 |
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis.
Topics: Acetylcysteine; Adult; Azathioprine; Humans; Idiopathic Pulmonary Fibrosis; Network Meta-Analysis; Sildenafil Citrate | 2022 |
6 trial(s) available for azathioprine and acetylcysteine
Article | Year |
---|---|
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity | 2005 |
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Europe; Exercise Test; Female; Forced Expiratory Volume; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Patient Dropouts; Prednisone; Pulmonary Diffusing Capacity; Respiratory System Agents; Severity of Illness Index; Time Factors; Treatment Outcome; Vital Capacity | 2009 |
[Comments of the DGP on the press release dated 21.10. 2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients].
Topics: Acetylcysteine; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Middle Aged; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Respiratory System Agents; Treatment Outcome | 2011 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Prednisone; Pulmonary Fibrosis; Treatment Outcome; Vital Capacity | 2012 |
Treatment switching in idiopathic pulmonary fibrosis: from triple therapy to enrollment into a clinical investigational drug trial.
Topics: Acetylcysteine; Azathioprine; Double-Blind Method; Drugs, Investigational; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Treatment Outcome | 2013 |
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Idiopathic Pulmonary Fibrosis; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Treatment Failure; Vital Capacity | 2014 |
23 other study(ies) available for azathioprine and acetylcysteine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine.
Topics: Acetylcysteine; Animals; Azathioprine; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Guanidines; Liver; Liver Diseases; Male; Rats; Rats, Wistar | 2003 |
Azathioprine acts upon rat hepatocyte mitochondria and stress-activated protein kinases leading to necrosis: protective role of N-acetyl-L-cysteine.
Topics: Acetylcysteine; Animals; Apoptosis; Azathioprine; Caspase 3; Caspases; Cell Survival; Cytochromes c; DNA; DNA Fragmentation; Glutathione; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Male; Mitochondria, Liver; Mitogen-Activated Protein Kinase 3; Necrosis; Oxygen Consumption; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Stress, Physiological; Superoxides; Tetrazolium Salts; Thiazoles; Thymidine; Tritium | 2004 |
Antioxidant therapy for idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Glutathione; Humans; Lung; Prednisone; Pulmonary Fibrosis | 2005 |
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
Topics: Acetylcysteine; Antioxidants; Azathioprine; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Prednisolone; Pulmonary Fibrosis | 2006 |
Azathioprine hepatotoxicity and the protective effect of liquorice and glycyrrhizic acid.
Topics: Acetylcysteine; Animals; Azathioprine; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Glycyrrhiza; Glycyrrhizic Acid; Hepatocytes; Humans; Immunosuppressive Agents; Male; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley; Species Specificity | 2006 |
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe?
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Evidence-Based Medicine; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity | 2006 |
Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis.
Topics: Acetylcysteine; Azathioprine; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Therapy, Combination; Gene Frequency; Genetic Testing; Genotype; Humans; Idiopathic Pulmonary Fibrosis; Leukopenia; Methyltransferases; Models, Economic; Patient Selection; Pharmacogenetics; Phenotype; Quality-Adjusted Life Years; Respiratory System Agents; Steroids; Treatment Outcome | 2010 |
Hot off the breath: triple therapy for idiopathic pulmonary fibrosis--hear the PANTHER roar.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Middle Aged; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Respiratory System Agents | 2012 |
Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.
Topics: Acetylcysteine; Azathioprine; Drug Therapy, Combination; Expectorants; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Prednisolone | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
Topics: Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Adult; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Child; Drug Therapy, Combination; Expectorants; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2013 |
Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Alveolitis, Extrinsic Allergic; Azathioprine; Diagnosis, Differential; Disease Management; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Prednisolone; Pulmonary Emphysema; Radiography; Smoking | 2013 |
Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.
Topics: Acetylcysteine; Azathioprine; Disease Management; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Oxygen Inhalation Therapy; Phenylpropionates; Prednisolone; Pulmonary Emphysema; Pulmonary Fibrosis; Pyridazines; Radiography; Smoking | 2013 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
[Pulmonary fibrosis].
Topics: Acetylcysteine; Azathioprine; Clinical Trials as Topic; Forecasting; Glucocorticoids; Humans; Indoles; Multicenter Studies as Topic; Prognosis; Pulmonary Fibrosis; Pyridones | 2016 |